O06.2 Syphilis not associated with neurocognitive outcomes in people living with HIV in Ontario Canada

B. Christensen, F. Tavangar, A. Kroch, A. Burchell, S. Rourke, Rodney K. Rousseau, L. Light, T. Bekele, D. Tan
{"title":"O06.2 Syphilis not associated with neurocognitive outcomes in people living with HIV in Ontario Canada","authors":"B. Christensen, F. Tavangar, A. Kroch, A. Burchell, S. Rourke, Rodney K. Rousseau, L. Light, T. Bekele, D. Tan","doi":"10.1136/SEXTRANS-2021-STI.81","DOIUrl":null,"url":null,"abstract":"Background About 40–60% of people living with HIV (PLWH) experience neurocognitive impairments, irrespective of antiretroviral status. We hypothesized that a history of syphilis would be associated with worse neurocognitive outcomes in this population. Methods We conducted a retrospective study of PLWH enrolled between 2008–2017 in an Ontarian HIV cohort. Cognitive outcomes were the most recent measurements of: 1) self-reported MOS-HIV 4-item cognitive scale; 2) average T-score (ATS) based on formal neuropsychological testing of complex attention, speed of processing, and learning/memory; and 3) global deficit score (GDS) dichotomized into impaired/unimpaired. Syphilis history was based on chart review or lab data. We compared median MOS-HIV and ATS using Wilcoxon rank-sum tests, and proportion impaired on GDS using Chi-square/Fisher test. Multivariable models were fitted to estimate the association between syphilis and each outcome, adjusted for age, education, race, income, years of HIV, nadir and most recent CD4 count, most recent viral load, methamphetamine use, depression, and number of prior neurocognitive tests. Results Of 1434 participants, 76.4% were male at birth and 50.6% were white. At the time of the most recent MOS-HIV, median age was 47 (IQR: 37,54), median CD4 count was 517.5 (IQR: 360,678) cells/mm3 and 80.2% had HIV viral load Conclusion Among PLWH in care in Ontario, prior syphilis was not associated with worse neurocognitive outcomes according to self-reported scales or formal neuropsychological testing. Continued study into the etiology of neurocognitive impairments in PLWH is required.","PeriodicalId":330607,"journal":{"name":"Syphilis clinical","volume":"40 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Syphilis clinical","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/SEXTRANS-2021-STI.81","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background About 40–60% of people living with HIV (PLWH) experience neurocognitive impairments, irrespective of antiretroviral status. We hypothesized that a history of syphilis would be associated with worse neurocognitive outcomes in this population. Methods We conducted a retrospective study of PLWH enrolled between 2008–2017 in an Ontarian HIV cohort. Cognitive outcomes were the most recent measurements of: 1) self-reported MOS-HIV 4-item cognitive scale; 2) average T-score (ATS) based on formal neuropsychological testing of complex attention, speed of processing, and learning/memory; and 3) global deficit score (GDS) dichotomized into impaired/unimpaired. Syphilis history was based on chart review or lab data. We compared median MOS-HIV and ATS using Wilcoxon rank-sum tests, and proportion impaired on GDS using Chi-square/Fisher test. Multivariable models were fitted to estimate the association between syphilis and each outcome, adjusted for age, education, race, income, years of HIV, nadir and most recent CD4 count, most recent viral load, methamphetamine use, depression, and number of prior neurocognitive tests. Results Of 1434 participants, 76.4% were male at birth and 50.6% were white. At the time of the most recent MOS-HIV, median age was 47 (IQR: 37,54), median CD4 count was 517.5 (IQR: 360,678) cells/mm3 and 80.2% had HIV viral load Conclusion Among PLWH in care in Ontario, prior syphilis was not associated with worse neurocognitive outcomes according to self-reported scales or formal neuropsychological testing. Continued study into the etiology of neurocognitive impairments in PLWH is required.
O06.2加拿大安大略省艾滋病毒感染者的梅毒与神经认知结果无关
背景:大约40-60%的艾滋病毒感染者(PLWH)经历神经认知障碍,与抗逆转录病毒状态无关。我们假设在这个人群中,梅毒病史与较差的神经认知结果有关。方法:我们对2008-2017年在安大略省HIV队列中登记的PLWH进行了回顾性研究。认知结果是最近的测量结果:1)自我报告的MOS-HIV 4项认知量表;2)基于复杂注意力、加工速度和学习/记忆的正式神经心理测试的平均t -分数(ATS);3)全球赤字评分(GDS)分为受损/未受损。梅毒病史以病历或实验室数据为依据。我们使用Wilcoxon秩和检验比较MOS-HIV和ATS的中位数,使用卡方/Fisher检验比较GDS的受损比例。拟合多变量模型来估计梅毒与每个结果之间的关系,并根据年龄、教育程度、种族、收入、HIV感染年数、最低点和最近的CD4计数、最近的病毒载量、甲基苯丙胺使用、抑郁症和以前的神经认知测试次数进行调整。结果1434名参与者中,76.4%出生时为男性,50.6%为白人。在最近的MOS-HIV感染时,中位年龄为47岁(IQR: 37,54),中位CD4计数为517.5 (IQR: 360,678)细胞/mm3, 80.2%有HIV病毒载量结论在安大略省护理的PLWH中,根据自我报告的量表或正式的神经心理测试,既往梅毒与较差的神经认知结果无关。需要继续研究PLWH患者神经认知障碍的病因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信